Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017

Table 3 Anti-HBs level by number and type of vaccination at time of examination, weighted proportions (N = 2,489)

	Total n	Anti-HBs level < 10 IU/L		Anti-HBs level 10–99 IU/L		Anti-HBs level ≥ 100 IU/L
	Total n	n	% [95%CI]	n	% [95%CI]	n	% [95%CI]
Recommended schedule (≥ 3 doses)
Yes	2,130	818	35.8 [33.2–38.4]	764	35.6 [32.8–38.5]	548	28.6 [24.8–29.1]
No	359	141	39.7 [33.7–45.9]	136	36.0 [30.1–42.3]	82	24.4 [19.7–29.7]
Recommended schedule
3 doses	454	201	45.1 [39.4–51.0]	147	31.5 [26.3–37.1]	106	23.5 [18.8–29.0]
4 doses	1,644	610	33.5 [31.0–36.5]	610	37.1 [33.9–40.5]	424	29.4 [26.5–32.3]

ISSN: 1471-2334